J. Berlanga-Acosta

发表

Intra‐lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo‐controlled, double‐blind study

W. Savigne, P. López-Saura, J. Fernández-Montequín, 2009, International wound journal.

Intralesional administration of epidermal growth factor‐based formulation (Heberprot‐P) in chronic diabetic foot ulcer: treatment up to complete wound closure

J. Fernández-Montequín, Luis H Martinez, E. L. Mola, 2009, International wound journal.

Burn injury insulin resistance and central nervous system complications: A review

P. Valdés-Sosa, J. Berlanga-Acosta, Y. Mendoza-Marí, 2020 .

Epidermal growth factor effect on lipopolysaccharide-induced inflammation in fibroblasts derived from diabetic foot ulcer

J. Berlanga-Acosta, Y. Mendoza-Marí, Nadia Rodríguez-Rodríguez, 2022, Scars, burns & healing.

GHRP-6 , a novel candidate for prevention and treatment of fibrotic disorders

J. Berlanga-Acosta, D. Vázquez-Blomquist, José Suárez-Alba, 2017 .

Growth hormone‐releasing peptide 6 prevents cutaneous hypertrophic scarring: early mechanistic data from a proteome study

L. Betancourt, V. Besada, L. González, 2018, International wound journal.

Diabetic lower extremity wounds: the rationale for growth factors‐based infiltration treatment

J. Berlanga-Acosta, 2011, International wound journal.

Intralesional Infiltrations of Arteriosclerotic Tissue Cells-Free Filtrate Reproduce Vascular Pathology in Healthy Recipient Rats

R. Playford, J. Berlanga-Acosta, O. Reyes-Acosta, 2022, International journal of molecular sciences.

Review: Insulin resistance and mitochondrial dysfunction following severe burn injury

R. Playford, J. Berlanga-Acosta, Y. Mendoza-Marí, 2020, Peptides.

Intestinal growth in parenterally-fed rats induced by the combined effects of glucagon-like peptide 2 and epidermal growth factor.

A. Forbes, J. Walters, R. Playford, 2005, JPEN. Journal of parenteral and enteral nutrition.

Global brain ischemia in Mongolian gerbils: assessing the level of anastomosis in the cerebral circle of Willis.

J. S. Alba, J. Berlanga-Acosta, H. Pérez-Saad, 2012, Acta neurobiologiae experimentalis.

Potency and stability of C terminal truncated human epidermal growth factor

A. Edwards, R. Playford, K. Lakhoo, 2000, Gut.

High glucose burden inhibits EGFR/PI3K/AKT1/mTOR signaling pathway in cutaneous fibroblasts

J. Berlanga-Acosta, Y. Mendoza-Marí, Ariana García-Ojalvo, 2014 .

Cell-Free Filtrates (CFF) as Vectors of a Transmissible Pathologic Tissue Memory Code: A Hypothetical and Narrative Review

J. Berlanga-Acosta, Y. Mendoza-Marí, Diana García del Barco Herrera, 2022, International journal of molecular sciences.

Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects

J. Berlanga-Acosta, F. Hernández-Bernal, Y. Mendoza-Marí, 2017, Clinical Medicine Insights. Cardiology.

Growth hormone releasing peptide-6 (GHRP-6) and other related secretagogue synthetic peptides: A mine of medical potentialities for unmet medical needs

G. Nieto, J. Berlanga-Acosta, Ernesto López-Mola, 2016 .

Keratinocyte Growth Factor and Epidermal Growth Factor Can Reverse the Intestinal Atrophy Associated with Elemental Diets in Mice

R. Goodlad, N. Mandir, J. Berlanga-Acosta, 2003, Experimental physiology.

Growth Hormone Releasing Peptide 6 (GHRP6) reduces liver fibrosis in CCl4 chronically intoxicated rats

M. Ochagavía, Jamilet Miranda, R. Bringas, 2012 .

epidermal growth factor Potency and stability of C terminal truncated human

R. Playford, K. Lakhoo, J. Berlanga-Acosta, 2000 .

Detrimental impact of acute and chronic glucose burden in wound-healing cells : fibroblasts , myofibroblasts and vascular precursor cells

P. López-Saura, J. Berlanga-Acosta, Marianela García-Siverio, 2012 .

Growth hormone and epidermal growth factor together enhance amino acid transport systems B(0,+) and A in remnant small intestine after massive enterectomy.

H. Sax, E. Ray, C. Ryan, 2003, The Journal of surgical research.

ATB0/ASCT2 expression in residual rabbit bowel is decreased after massive enterectomy and is restored by growth hormone treatment.

H. Sax, E. Ray, T. Ziegler, 2004, The Journal of nutrition.

Medical Practice Confirms Clinical Trial Results of the Use of Intralesional Human Recombinant Epidermal Growth Factor in Advanced Diabetic FootUlcers

P. López-Saura, J. Fernández-Montequín, C. Valenzuela-Silva, 2013 .

Intralesional Human Recombinant Epidermal Growth Factor for the Treatment of Advanced Diabetic Foot Ulcer: From Proof of Concept to Confirmation of the Efficacy and Safety of the Procedure

W. Savigne, P. López-Saura, J. Fernández-Montequín, 2011 .

Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications

P. López-Saura, J. Gavilondo-Cowley, J. Berlanga-Acosta, 2009, International wound journal.

Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation

P. López-Saura, J. Fernández-Montequín, C. Valenzuela-Silva, 2007, International wound journal.

Epidermal Growth Factor (EGF) intralesional infiltrations: From the bench to the diabetic ulcers cells

G. Nieto, J. Berlanga-Acosta, Y. Mendoza-Marí, 2019, Integrative Molecular Medicine.

Histological and Transcriptional Expression differences between Diabetic Foot and Pressure Ulcers

J. Berlanga-Acosta, José Suárez-Alba, Y. Mendoza-Marí, 2013 .

Gastrointestinal cell proliferation and crypt fission are separate but complementary means of increasing tissue mass following infusion of epidermal growth factor in rats

R. Playford, R. Goodlad, N. Mandir, 2001, Gut.

epidermal growth factor in rats increasing tissue mass following infusion of are separate but complementary means of Gastrointestinal cell proliferation and crypt fission

R. Goodlad, N. Mandir, J. Berlanga-Acosta, 2001 .

Epidermal Growth Factor (EGF) and Platelet-Derived Growth Factor (PDGF) as Tissue Healing Agents: Clarifying Concerns about their Possible Role in Malignant Transformation and Tumor Progression

J. Gavilondo-Cowley, J. Berlanga-Acosta, G. Guillén-Nieto, 2011 .

Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics' Impaired Healing

G. Schultz, J. Berlanga-Acosta, Marianela García-Siverio, 2012, BioMed research international.

Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review

M. L. Bringas-Vega, P. Valdés-Sosa, M. Valdés-Sosa, 2020, Frontiers in Endocrinology.

Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice.

R. Playford, R. Goodlad, O. Bashir, 2003, Clinical science.

Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2

J. Berlanga-Acosta, D. Garcı́a-del-Barco, F. D. Martos-Benítez, 2021, Frontiers in Immunology.

Cellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity

M. L. Bringas-Vega, P. Valdés-Sosa, J. Berlanga-Acosta, 2020, Frontiers in Endocrinology.

Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome

J. Fernández-Montequín, J. Berlanga-Acosta, H. Pérez-Saad, 2017, BioMed research international.

Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients.

J. Berlanga-Acosta, Y. Mendoza-Marí, Ariana García-Ojalvo, 2021, MEDICC review.

Heberprot-P's Effect on Gene Expression in Healing Diabetic Foot Ulcers.

J. Berlanga-Acosta, J. Á. Galván-Cabrera, Á. Tuero-Iglesias, 2018, MEDICC review.

Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.

R. Playford, J. Berlanga-Acosta, A. Sinha, 2003, The New England journal of medicine.

Epidermal growth factor enemas for induction of remission in left-sided ulcerative colitis

P. López-Saura, C. Valenzuela-Silva, J. Berlanga-Acosta, 2013 .

Epidermal Growth Factor in Healing Diabetic Foot Ulcers: From Gene Expression to Tissue Healing and Systemic Biomarker Circulation.

J. Berlanga-Acosta, Y. Mendoza-Marí, Ariana García-Ojalvo, 2020, MEDICC review.

Cellular and molecular insights into the wound healing mechanism in diabetes

J. Berlanga-Acosta, Y. Mendoza-Marí, Calixto Valdez-Pérez, 2010 .

Intralesional Infiltrations of Cell-Free Filtrates Derived from Human Diabetic Tissues Delay the Healing Process and Recreate Diabetes Histopathological Changes in Healthy Rats

R. Playford, J. Berlanga-Acosta, Y. Mendoza-Marí, 2021, Frontiers in Clinical Diabetes and Healthcare.

Expression of cell proliferation cycle negative regulators in fibroblasts of an ischemic diabetic foot ulcer. A clinical case report

D. G. Armstrong, J. Berlanga-Acosta, Y. Mendoza-Marí, 2013, International wound journal.

Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review

J. Berlanga-Acosta, J. Llibre-Guerra, G. Guillén-Nieto, 2022, Frontiers in Aging Neuroscience.

Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis

J. Berlanga-Acosta, M. Béquet-Romero, G. Pentón-Rol, 2023, Archives of Virology.

Growth hormone and epidermal growth factor together enhance amino acid transport systems B0,+ and A in remnant small intestine after massive enterectomy.

H. Sax, E. Ray, C. Ryan, 2003, Journal of Surgical Research.

Chronic Wounds with Emphasis in Diabetic Foot Ulcers

D. Armstrong, G. Schultz, J. Berlanga-Acosta, 2014, BioMed research international.

Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence: Hypothetical Reflections

J. Berlanga-Acosta, Ariana García-Ojalvo, G. Guillén-Nieto, 2023, International journal of molecular sciences.

Torpid Diabetic Wound Healing: Evidence on the Role of Epigenetic Forces

J. Berlanga-Acosta, Ileydis Iglesias-Marichal, A. García, 2015 .

Application of the cDNA macroarray technology aimed to detect gene expression changes following burn injury

D. Cibrian, J. Berlanga-Acosta, I. Guillen, 2005 .

P. López-Saura, J. Fernández-Montequín, C. Valenzuela-Silva, 2009, International wound journal.

Open Access book

P. López-Saura, J. Fernández-Montequín, C. Valenzuela-Silva, 2017 .

Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms

J. Berlanga-Acosta, Linlin Wang, José Suárez-Alba, 2024, Frontiers in pharmacology.